SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients-Reference-Cited by-同舟云学术

SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients

Published:2013-10-16 Issue:7475 Volume:503 Page:267-271
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shcheglovitov Aleksandr,Shcheglovitova Olesya,Yazawa Masayuki,Portmann Thomas,Shu Rui,Sebastiano Vittorio,Krawisz Anna,Froehlich Wendy,Bernstein Jonathan A.,Hallmayer Joachim F.,Dolmetsch Ricardo E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature12618.pdf

Reference32 articles.

1. Phelan, K. & McDermid, H. E. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol. Syndromol. 2, 186–201 (2012)

2. Boeckers, T. M., Bockmann, J., Kreutz, M. R. & Gundelfinger, E. D. ProSAP/Shank proteins – a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J. Neurochem. 81, 903–910 (2002)

3. Sheng, M. & Kim, E. The Shank family of scaffold proteins. J. Cell Sci. 113, 1851–1856 (2000)

4. Boccuto, L. et al. Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur. J. Hum. Genet. 21, 310–316 (2013)

5. Durand, C. M. et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genet. 39, 25–27 (2007)

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors;Nature Communications;2024-09-10

2. Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models;Translational Psychiatry;2024-06-10

3. Shank3 deficiency elicits autistic-like behaviors by activating p38α in hypothalamic AgRP neurons;Molecular Autism;2024-04-03

4. An Update on Psychopharmacological Treatment of Autism Spectrum Disorder;Focus;2024-04

5. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells;eLife;2024-03-25